X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IOBT

Closed

Io Biotech Inc

1.38
-0.01 (-0.72%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.39
Day's Range: 1.3 - 1.4396
Send
When Written:
 
1.86
IO Biotech Inc is a clinical-stage biotechnology company headquartered in Copenhagen, Denmark. The company is focused on developing novel immunotherapies for the treatment of cancer and infectious diseases. IO Biotech's lead product candidate, IO102, is a first-in-class immune modulatory molecule that has shown promising results in preclinical and early clinical studies. The company is also developing a pipeline of other immunotherapies that target various aspects of the immune system to enhance the body's ability to fight cancer and infectious diseases. IO Biotech has partnerships with several leading pharmaceutical companies and academic institutions to advance its research and development programs.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X